29 results
8-K
EX-99.1
UNCY
Unicycive Therapeutics Inc
14 Nov 23
Unicycive Announces Third Quarter 2023 Financial Results and Provides Business Update
4:42pm
offset by increases in labor costs of $0.1 million and non-cash stock compensation costs of $0.3 million.
General and Administrative (G&A) Expenses: G
PRE 14A
2it2wki4ph lv
18 Apr 23
Preliminary proxy
5:25pm
DEF 14A
pd0ext x5r2f3uu9idk
19 Apr 22
Definitive proxy
4:00pm
10-K
u62t4
31 Mar 22
Annual report
6:18am
10-Q
v9wh9q7 h3ucf
16 Aug 21
Quarterly report
6:06am
424B4
ee92veckaq wn1mtnz
14 Jul 21
Prospectus supplement with pricing info
1:59pm